Drug Shortage Report for OMNARIS
| Report ID | 175522 |
| Drug Identification Number | 02303671 |
| Brand name | OMNARIS |
| Common or Proper name | Omnaris |
| Company Name | COVIS PHARMA GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | CICLESONIDE |
| Strength(s) | 50MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 120 |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-12-05 |
| Actual start date | 2022-12-05 |
| Estimated end date | 2022-12-16 |
| Actual end date | 2022-12-09 |
| Shortage status | Resolved |
| Updated date | 2024-02-07 |
| Company comments | Shortage was resolved December 9 2022. There is currently no shortage of Omnaris. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GRAFENAUWEG 12 ZUG, ZUG SWITZERLAND 6300 |
| Company contact information | Covis Pharma GmbH Grafenauweg 12 Zug, 6300 Switzerland |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-11-24 | English | Compare |
| v2 | 2022-11-24 | English | Compare |
| v3 | 2022-11-24 | French | Compare |
| v4 | 2022-11-24 | French | Compare |
| v5 | 2022-11-24 | French | Compare |
| v6 | 2022-11-24 | English | Compare |
| v7 | 2022-11-24 | French | Compare |
| v8 | 2022-12-06 | English | Compare |
| v9 | 2024-02-07 | English | Compare |
| v10 | 2024-02-07 | French | Compare |
| v11 | 2024-02-07 | French | Compare |
Showing 1 to 11 of 11